Rankings
▼
Calendar
CMPX
Compass Therapeutics, Inc.
$764M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$11M
EPS (Diluted)
$-2.15
Cash Flow
Operating Cash Flow
-$10,477
Free Cash Flow
-$10,796
Stock-Based Comp.
$255
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$45M
Cash & Equivalents
-$58M
← FY 2019
All Quarters
Q2 2019 →
CMPX Q1 2019 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
